Article Data

  • Views 1402
  • Dowloads 144

Original Research

Open Access

Neoadjuvant chemotherapy followed by extended-field concurrent chemoradiotherapy in squamous cell carcinoma of the cervix with positive paraaortic lymph nodes: two cases

  • M. Hirakawa1,*,
  • Y. Nagai1
  • C. Yagi1
  • T. Nashiro1
  • M. Inamine1
  • Y. Aoki1

1Department of Obstetrics and Gynecology, Faculty of Medicine, University of the Ryukyus, Okinawa, Japan

DOI: 10.12892/ejgo200802171 Vol.29,Issue 2,March 2008 pp.171-173

Published: 10 March 2008

*Corresponding Author(s): M. Hirakawa E-mail: h013916@med.u-ryukyu.ac.jp

Abstract

Purpose: To report the feasibility of neoadjuvant chemotherapy (NAC) followed by extended-field concurrent chemoradiotherapy (EF-CCRT) for squamous cell carcinoma of the cervix (CC) with paraaortic lymph node (PAN) metastasis. Methods: Two patients were diagnosed with CC with positive PAN, and received two courses of cisplatin (120 mg/m(2)) in a neoadjuvant setting. They then received extended-field, external-beam radiotherapy (50.4 Gy) followed by intracavitary brachytherapy concurrently with cisplatin (20 mg/m(2) x 5 days) at 21-day intervals. Results: EF-CCRT was interrupted in one patient for five days because of grade 4 neutropenia. No severe late toxicities were observed. The two patients are alive with no evidence of recurrence at present. Conclusions: NAC followed by EF-CCRT is feasible and may improve the survival outcome of patients with CC with positive PAN.

Keywords

Cervical cancer; Paraaortic lymph node metastasis; Neoadjuvant chemotherapy; Concurrent chemoradiotherapy

Cite and Share

M. Hirakawa,Y. Nagai,C. Yagi,T. Nashiro,M. Inamine,Y. Aoki. Neoadjuvant chemotherapy followed by extended-field concurrent chemoradiotherapy in squamous cell carcinoma of the cervix with positive paraaortic lymph nodes: two cases. European Journal of Gynaecological Oncology. 2008. 29(2);171-173.

References

[1] Grigsby P.W., Perez C.A., Chao K.S. et al.: “Radiation therapy for carcinoma of the cervix with biopsy-proven positive paraaortic lymph nodes”. Int. J. Radiat. Oncol. Biol. Phys., 2001, 49, 733.

[2] Vigliotte A.P., Wen B.C., Hussey D.H. et al.: “Extended field irradiation for carcinoma of the uterine cervix with positive periaortic nodes”. Int. J. Radiat. Oncol. Biol. Phys., 1992, 23, 501.

[3] Grigsby P.W., Heydon K., Mutch D.G. et al.: “Long-term followup of RTOG 92-10: cervical cancer with positive paraaortic lymph nodes”. Int. J. Radiat. Oncol. Biol. Phys., 2001, 51, 982.

[4] Varia M.A., Bundy B.N., Deppe G. et al.: “Cervical carcinoma metastatic to paraaortic nodes: extended field radiation therapy with concomitant 5-fluorouracil and cisplatin chemotherapy: a Gynecologic Oncology Group study”. Int. J. Radiat. Oncol. Biol. Phys., 1998, 42, 1015.

[5] Saad A., Simon S. Lo, Ihn Han et al.: “Radiation therapy with or without chemotherapy for cervical cancer with periaortic lymph node metastasis”. Am. J. Clin. Oncol., 2004, 27, 256.

[6] Markman M., D’acquisto R., Iannotti N. et al.: “Phase-1 trial of high-dose intravenous cisplatin with simultaneous intravenous sodium thiosulfate”. J. Cancer Res. Clin. Oncol., 1991, 117, 151.

[7] Fields A.L.: “Mature results of a phase II trial of concomitant cisplatin/ pelvic radiotherapy for locally advanced squamous cell carcinoma of the cervix”. Gynecol. Oncol., 1996, 61, 416.

[8] Berman M.L., Keys H., Creasman W. et al.: “Survival and patterns of recurrence in cervical cancer metastatic to periaortic lymph nodes (a Gynecologic Oncology Group study)”. Gynecol. Oncol., 1984, 19, 8.

[9] Paccagnella A. et al.: “Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: A study by the Gruppo di Studio sui Tumori della Testa e del Collo”. J. Natl. Cancer Inst., 1994, 86, 265.

[10] Department of Veterans Affairs Laryngeal Cancer Study Group: “Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer”. N. Engl. J. Med., 1991, 324, 1685.

Submission Turnaround Time

Top